Call us on
0370 1500 100
I am a solicitor in the Medical Product Liability and Medical Negligence team.
My team and I deal with national and international group actions in relation to defective medical devices and pharmaceuticals or sub-standard medical treatment.
I provide advice and pursue legal actions for the recovery of compensation for victims of defective medical products; I do not represent the manufacturers.
I have been involved in this sort of work since I qualified as a solicitor in 2008.
I tend to represent individuals, or groups of individuals, pursuing claims against multi-national pharmaceutical companies. Where harm has been done, I find it very satisfying to play my part in holding big business to account, and hopefully reducing the risk of the same harm happening again in the future.
Irwin Mitchell is one of the few firms in the UK with the expertise and resources to deal with the kind of case that I work on. From a professional point of view, I feel privileged to be working on the kind of technically challenging cases we are presented with.
I am lucky enough to live on the edge of the Peak District, so I like to get out there for a walk or a bike ride as often as I can. I play golf every now and then and try to read when I can.
“We have long-held concerns regarding the safety and quality of E-cigarette products, with specific issues relating to the design of batteries and whether the coating on them is sufficiently robust.
“The anode and cathode parts of the batteries in question are arranged concentrically and they are positioned very close to one another. If damage occurs to the protective outer coating, then contact with items like coins can short the batteries and cause ‘venting’. The effect of that is similar to a roman candle igniting in the user’s pocket.
“We are pleased to have helped our clients receive a settlement regarding their experiences, albeit without an admission of liability.
“We believe that it is key that products are stored and provided to consumers in the right manner, while consumers should also be given advice on the correct way to store and use such items.
“Such products are hugely popular and it is vital that everything possible is done to protect users from any potential risk of harm. Therefore we would urge manufacturers to also review the design of the products to ensure they are fit for purpose.”
“It’s very worrying to once again hear concerns being raised regarding the safety of a medical device.
“Sadly the nature of our work means we have seen numerous cases where patients have suffered as a result of problems with such devices and it is absolutely vital that everything possible is done to protect patients here.
“Safety has to come first and it is essential that the MHRA works quickly and thoroughly to get to the bottom of the issues identified. Lessons must be learned from a matter like this to ensure that patients are simply never exposed to unnecessary risks.”
“This is a significant investigation which asks important questions about the medical device market and the way it is regulated across the globe.
“The ICIJ conclude, and we agree that the system for testing and approving medical devices is currently inadequate. The requirement for clinical trials of new devices is very much less stringent than that for pharmaceuticals which simply doesn’t make sense for complex implantable devices like prosthetic joints or pacemakers. These devices have the potential to cause serious harm or death in the event of failure, and should be subject to far more extensive testing before they are released for use.
“At Irwin Mitchell we have been saying for some time that the CE mark system involves a fundamental conflict of interest, in which the business of the ‘notified bodies’ designated to provide marketing approval for medical devices depends upon provision of approval at the best price. Effectively, these notified bodies compete with each other to award approval to manufacturers. A stronger and safer system would see an independent body put in place to manage the suitability and safety of medical devices.
"The ICIJ should be applauded for their work on this subject, and for their contribution to making medical devices safer for all of us."
“The problem appears to be that the ‘MV sensor’ is oversensitive, which leads to malfunction of the device and associated morbidity.
“Boston Scientific is working on a software fix, which is expected to be available in October 2018. In the meantime, the advice to clinicians is to switch off the MV sensor, which can create physiological problems in itself, as the activity of the pacemaker is altered.
“The recall notice states that 32,500 individuals in the UK are affected, and there have been 8 deaths or serious injuries to date. This is a very serious issue and it is important that it is properly investigated as soon as possible to ensure patient safety for all of those affected.
“We are now working with our client to ensure they get the help and support they need as we investigate the problems they have reported.”
Request A Call Back
Enter your details below and we'll call you back, at a time of your choice.
This data will only be used by Irwin Mitchell for processing your query and for no other purpose.